Burning Rock Biotech (BNR) Retained Earnings (2019 - 2025)
Burning Rock Biotech has reported Retained Earnings over the past 7 years, most recently at -$22.9 million for Q4 2025.
- For Q4 2025, Retained Earnings fell 3.9% year-over-year to -$22.9 million; the TTM value through Dec 2025 reached -$22.9 million, down 3.9%, while the annual FY2025 figure was -$23.2 million, 95.97% up from the prior year.
- Retained Earnings for Q4 2025 was -$22.9 million at Burning Rock Biotech, down from -$22.5 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$21.6 million in Q2 2023 and troughed at -$535.2 million in Q4 2023.
- A 5-year average of -$87.2 million and a median of -$23.1 million in 2024 define the central range for Retained Earnings.
- Biggest five-year swings in Retained Earnings: crashed 1278.49% in 2021 and later skyrocketed 95.89% in 2024.
- Year by year, Retained Earnings stood at -$348.6 million in 2021, then dropped by 29.07% to -$449.9 million in 2022, then dropped by 18.96% to -$535.2 million in 2023, then skyrocketed by 95.89% to -$22.0 million in 2024, then decreased by 3.9% to -$22.9 million in 2025.
- Business Quant data shows Retained Earnings for BNR at -$22.9 million in Q4 2025, -$22.5 million in Q3 2025, and -$22.1 million in Q2 2025.